Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 276
Titolo Autore(i) Anno Periodico Editore Tipo File
Imatinib Mesylate Determines a High Frequency of Major Molecular Responses in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Phase Chronic Myeloid Leukemia on Behalf of the GIMEMA CML WP. Iacobucci, I; Testoni, N; Rosti, G; Amabile, M; Poerio, A; Soverini, S; Colarossi, S; Gnani, A; O...ttaviani, E; Castagnetti, F; Terragna, C; Renzulli, M; Grafone, T; Cilloni, D; Pane, F; Saglio, G; Baccarani, M; Martinelli, G 2005-01-01 - - 4.02 Riassunto (Abstract) -
Identification and validation of PDGFRa as therapeutic target for PTCL-NOS. Piccaluga P.P.; Rossi M.; Iacobucci I.; Tazzari P.L.; Agostinelli C.; Zinzani P.L.; Bagnara G.P.;... Martinelli G.; Dalla Favera R.; Baccarani M.; Pileri S.A. 2006-01-01 - s.n 4.02 Riassunto (Abstract) -
Presence or the Emergence of a F317L BCR-ABL Mutation May Be Associated With Resistance to Dasatinib in Philadelphia Chromosome Positive Leukemia S. Soverini;G. Martinelli;S. Colarossi;A. Gnani;F. Castagnetti;G. Rosti;C. Bosi;S. Paolini;M. Ron...doni;P. P. Piccaluga;F. Palandri;P. Giannoulia;G. Marzocchi;S. Luatti;N. Testoni;I. Iacobucci;D. Cilloni;G. Saglio;M. Baccarani 2006-01-01 JOURNAL OF CLINICAL ONCOLOGY - 1.01 Articolo in rivista -
Monitoring minimal residual disease and controlling drug resistance in chronicmyeloid leukaemia patients in treatment with imatinib as a guide to clinicalmanagement. Martinelli G; Iacobucci I; Soverini S; Cilloni D; Saglio G; Pane F; Baccarani M. 2006-01-01 HEMATOLOGICAL ONCOLOGY - 1.01 Articolo in rivista -
Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment. IACOBUCCI I; ROSTI G; AMABILE M; POERIO A; SOVERINI S; CILLONI D; TESTONI N; ABRUZZESE E; MONTEFU...SCO E; OTTAVIANI E; IULIANO F; RUSSO D; GOBBI M; ALIMENA G; MARTINO B; TERRAGNA C; PANE F; SAGLIO G; BACCARANI M; MARTINELLI G 2006-01-01 JOURNAL OF CLINICAL ONCOLOGY - 1.01 Articolo in rivista -
Contribution Of ABL Kinase Domain Mutations To Imatinib Resistance In Different Subsets Of Philadelphia-Positive Patients. By The GIMEMA Working Party On Chronic Myeloid Leukemia Soverini S; Colarossi S; Gnani A; Rosti G; Castagnetti F; Poerio A; Iacobucci I; Amabile M; Abruz...zese E; Orlandi E; Radaelli F; Ciccone F; Tiribelli M; di Lorenzo R; Caracciolo C; Izzo B; Pane F; Saglio G; Baccarani M; Martinelli G; on behalf of the GIMEMA Working Party on Chronic Myeloid Leukemia (GIMEMA-CML) 2006-01-01 CLINICAL CANCER RESEARCH - 1.01 Articolo in rivista -
Dual Src/Abl inhibitor SKI-606 binding mode in BCR-ABL kinase hypothesized on the basis of molecular docking studies Soverini S.; Tasco G.; Grafone T.; Colarossi S.; Gnani A.; Rosti G.; Castagnetti F.; Palandri F.;... Rondoni M.; Poerio A.; Iacobucci I.; Amabile M.; Baccarani M.; Casadio R.; Martinelli G. 2006-01-01 HAEMATOLOGICA - 4.02 Riassunto (Abstract) -
Binding Mode Of The Novel Dual SRC and ABL Inhibitor SKI-606 To The BCR-ABL Kinase As Predicted By Molecular Docking Studies Soverini S.; Tasco G.; Grafone T.; Colarossi S.; Gnani A.; Rosti G.; Castagnetti F.; Palandri F.;... Rondoni M.; Poerio A.; Iacobucci I.; Amabile M.; Baccarani M.; Casadio R.; Martinelli G. 2006-01-01 HAEMATOLOGICA - 4.02 Riassunto (Abstract) -
Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients. Iacobucci I; Saglio G; Rosti G; Testoni N; Pane F; Amabile M; Poerio A; Soverini S; Bassi S; Cill...oni D; Bassan R; Breccia M; Lauria F; Izzo B; Merante S; Frassoni F; Paolini S; Montefusco E; Baccarani M; Martinelli G 2006-01-01 CLINICAL CANCER RESEARCH - 1.01 Articolo in rivista -
Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients MARTINELLI G; IACOBUCCI I; ROSTI G; PANE F; AMABILE M; CASTAGNETTI F; CILLONI D; SOVERINI S; TEST...ONI N; SPECCHIA G; MERANTE S; ZACCARIA A; FRASSONI F; SAGLIO G; BACCARANI M. 2006-01-01 ANNALS OF ONCOLOGY - 1.01 Articolo in rivista -
Nilotinib: a novel encouraging therapeutic option for chronic myeloid leukemia patients with imatinib resistance or intolerance Martinelli G.; Iacobucci I.; Soverini S.; Palandri F.; Castagnetti F.; Rosti G.; Baccarani M. 2007-01-01 BIOLOGICS - 1.01 Articolo in rivista Martinelli_Biologics2007.pdf
Bcr-Abl Positive Chronic Myeloid Disorders. Risk stratification Models, Prognostic Variables Baccarani M.; Castagnetti F.; Iacobucci I.; Palandri F.; Pusiol A. 2007-01-01 - Informa healthcare - Taylor & Francis publishers 2.01 Capitolo / saggio in libro -
Resistance to tyrosine kinase inhibitors in Philadelphia chromosome-positive leukemias: which mutations matter? Soverini S.; Baccarani M.; Iacobucci I.; Martinelli G. 2007-01-01 CLINICAL LEUKEMIA - 1.01 Articolo in rivista -
MK-0457: a light at the end of the tunnel? Martinelli G.; Soverini S.; Iacobucci I.; Baccarani M. 2007-01-01 BLOOD - 1.04 Replica / breve intervento (e simili) -
Long-term molecular responses to imatinib in patients with chronic myeloid leukemia: comparison between complete cytogenetic responders treated in early and in late chronic phase Palandri F, Iacobucci I, Quarantelli F, Castagnetti F, Cilloni D, Baccarani M; GIMEMA Working Par...ty on CML. 2007-01-01 HAEMATOLOGICA - 1.01 Articolo in rivista -
Coding sequence and intron-exon junctions of the c-myb gene are intact in the chronic phase and blast crisis stages of chronic myeloid leukemia patients Bussolari R; Candini O; Colomer D; Corradini F; Guerzoni C; Mariani SA; Cattelani S; Silvestri C;... Pecorari L; Iacobucci I; Soverini S; Fasano T; Martinelli G; Cervantes F; Calabretta B. 2007-01-01 LEUKEMIA RESEARCH - 1.01 Articolo in rivista -
Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain Soverini S; Colarossi S; Gnani A; Castagnetti F; Rosti G; Bosi C; Paolini S; Rondoni M; Piccaluga... PP; Palandri F; Giannoulia P; Marzocchi G; Luatti S; Testoni N; Iacobucci I; Cilloni D; Saglio G; Baccarani M; Martinelli G. 2007-01-01 HAEMATOLOGICA - 1.01 Articolo in rivista -
The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study. Baccarani M; Cilloni D; Rondoni M; Ottaviani E; Messa F; Merante S; Tiribelli M; Buccisano F; Tes...toni N; Gottardi E; de Vivo A; Giugliano E; Iacobucci I; Paolini S; Soverini S; Rosti G; Rancati F; Astolfi C; Pane F; Saglio G; Martinelli G. 2007-01-01 HAEMATOLOGICA - 1.01 Articolo in rivista -
Monitoring BCR-ABL transcript levels by real-time quantitative polymerase chain reaction: a linear regression equation to convert from BCR-ABL/B2M ratio to estimated BCR-ABL/ABL ratio Iacobucci I; Galletti L; Amabile M; Soverini S; Baccarani M; Martinelli G. 2007-01-01 HAEMATOLOGICA - 1.01 Articolo in rivista -
Targeted therapy and the T315I mutation in Philadelphia-positive leukemias. Soverini S; Iacobucci I; Baccarani M; Martinelli G. 2007-01-01 HAEMATOLOGICA - 1.01 Articolo in rivista -
Mostrati risultati da 1 a 20 di 276
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile